ProPhase Labs (PRPH) EBIAT (2016 - 2025)
Historic EBIAT for ProPhase Labs (PRPH) over the last 16 years, with Q3 2025 value amounting to -$6.8 million.
- ProPhase Labs' EBIAT fell 382.57% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$50.3 million, marking a year-over-year decrease of 8139.5%. This contributed to the annual value of -$53.4 million for FY2024, which is 21798.36% down from last year.
- As of Q3 2025, ProPhase Labs' EBIAT stood at -$6.8 million, which was down 382.57% from -$4.5 million recorded in Q2 2025.
- In the past 5 years, ProPhase Labs' EBIAT registered a high of $12.5 million during Q1 2022, and its lowest value of -$34.4 million during Q4 2024.
- Over the past 5 years, ProPhase Labs' median EBIAT value was -$4.0 million (recorded in 2021), while the average stood at -$3.2 million.
- Over the last 5 years, ProPhase Labs' EBIAT had its largest YoY gain of 114017.68% in 2021, and its largest YoY loss of 209285.71% in 2021.
- ProPhase Labs' EBIAT (Quarter) stood at $10.6 million in 2021, then plummeted by 123.08% to -$2.4 million in 2022, then plummeted by 258.06% to -$8.8 million in 2023, then tumbled by 292.63% to -$34.4 million in 2024, then soared by 80.1% to -$6.8 million in 2025.
- Its last three reported values are -$6.8 million in Q3 2025, -$4.5 million for Q2 2025, and -$4.7 million during Q1 2025.